U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226700) titled 'Suzetrigine in Total Hip Arthroplasty' on Nov. 05.
Brief Summary: Total hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids, which can cause sedation, nausea, constipation, and long-term dependency. Evaluating Suzetrigine in this high-need population may improve recovery trajectories, reduce opioid consumption, and support enhanced recovery protocols. Given the growing surgical volume and the emphasis on opioid-spa...